A multilaboratory study demonstrates the potential for establishing quantitative targeted proteomic assays for moderately to highly abundant plasma proteins.
References
Adonna, T. et al. Nat. Biotechnol. 27, 633–641 (2009).
Bell, A.W. et al. Nat. Methods 6, 423–430 (2009).
Palmer, C. et al. PLoS ONE 3, e2633 (2008). http://www.plosone.org/doi/pone.0002633
Crump, C. et al. Cancer Epidemiol. Biomarkers Prev. 9, 1107–1111 (2000).
Brown, P. & Palmer, C. PLoS Med. (in the press).
Faca, V. et al. J. Proteome Res. 6, 3558–3565 (2007).
Whiteaker, J.R. et al. J. Proteome Res. 6, 828–836 (2007).
Schröder, F.H. et al. New Engl. J. Med. 360, 1320–1328 (2009).
Andriole, G.L. et al. New Engl. J. Med. 360, 1310–1319 (2009).
Pollack, A. New York Times A15 (1 June 2009). http://www.nytimes.com/2009/06/01/health/research/01cancer.html?_r=2&ref=health
Pollak, M.N. & Foulkes, W.D. Nat. Rev. Cancer 3, 297–303 (2003).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McIntosh, M., Fitzgibbon, M. Biomarker validation by targeted mass spectrometry. Nat Biotechnol 27, 622–623 (2009). https://doi.org/10.1038/nbt0709-622
Issue Date:
DOI: https://doi.org/10.1038/nbt0709-622
- Springer Nature America, Inc.
This article is cited by
-
iTRAQ-based quantitative analysis of age-specific variations in salivary proteome of caries-susceptible individuals
Journal of Translational Medicine (2018)
-
Proteomics retrenches
Nature Biotechnology (2010)